Prevalence of somatic diseases in adults with attention deficit hyperactivity disorder in Japan is highest in people aged ≥40 years with mental disorders: a cross-sectional study of a Japanese health insurance claims database
- PMID: 38419898
- PMCID: PMC10899330
- DOI: 10.3389/fpsyt.2024.1197513
Prevalence of somatic diseases in adults with attention deficit hyperactivity disorder in Japan is highest in people aged ≥40 years with mental disorders: a cross-sectional study of a Japanese health insurance claims database
Abstract
Introduction: Studies have reported an association between attention deficit hyperactivity disorder (ADHD) and somatic diseases; however, the correlation of mental disorders with the association between ADHD and somatic diseases remains uninvestigated. This study investigated and compared the prevalence of somatic diseases among adults with/without ADHD, stratified by the presence or absence of mental disorders.
Methods: This cross-sectional study (October 2020-September 2021), using data (June 2013-September 2021) from a Japanese health insurance claims database, included adult participants with a medical record of and receiving medication for ADHD (ADHD group); the control group (matched 1:5 by age/sex) comprised participants without ADHD. The prevalence and odds ratio (OR; ADHD versus control) of type 2 diabetes mellitus (T2DM), diabetes complications, hypertension, cardiovascular disease (CVD), dyslipidemia, gout and hyperuricemia, chronic obstructive pulmonary disease (COPD), non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH), and atopic dermatitis were investigated. Pooled ORs for stratified analysis were calculated using the Mantel-Haenszel method.
Results: In the matched analysis sets, the ORs for all somatic diseases were significantly higher for the ADHD group (n=15,028) versus the control group (n=74,796). On stratified analysis, the Mantel-Haenszel ORs were significant for NAFLD/NASH (1.53; 95% confidence interval [CI]: 1.34, 1.73), diabetes complications (1.39; 95% CI: 1.09, 1.77), and gout and hyperuricemia (1.34; 95% CI: 1.19, 1.51). Furthermore, the stratum-specific ORs for T2DM, hypertension, and dyslipidemia were >1 and <1 in the presence and absence of mental disorders, respectively. The prevalence of all somatic diseases except atopic dermatitis increased with age. For participants aged ≥40 years, the Mantel-Haenszel ORs were significant for all somatic diseases except CVD, COPD, and atopic dermatitis.
Conclusions: The prevalence of several somatic diseases, including chronic disorders, was high among adults with ADHD, particularly in those aged ≥40 years and those with mental disorders.
Keywords: Japan; attention deficit hyperactivity disorder; chronic diseases; health insurance claims database study; mental disorders; observational; somatic diseases; stratified analysis.
Copyright © 2024 Takaesu, Sato, Iwata, Takizawa, Miyauchi, Ishimoto and Kondo.
Conflict of interest statement
YI and YS are employees of Shionogi & Co., Ltd. SI and HM are employees of Shionogi Pharmacovigilance Center Co., Ltd. PT is an employee of Takeda Pharmaceutical Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. This study received funding from Shionogi & Co., Ltd. and Takeda Pharmaceutical Co., Ltd. The funder had the following involvement with the study: the study design, collection, analysis, interpretation of data, the writing of this article and the decision to submit it for publication.
Figures




Similar articles
-
Association between atopic diseases and attention-deficit/hyperactivity disorder in childhood: a population-based case-control study.Ann Epidemiol. 2013 Apr;23(4):185-8. doi: 10.1016/j.annepidem.2012.12.015. Epub 2013 Jan 29. Ann Epidemiol. 2013. PMID: 23375343
-
Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups.JAMA Netw Open. 2019 Nov 1;2(11):e1914344. doi: 10.1001/jamanetworkopen.2019.14344. JAMA Netw Open. 2019. PMID: 31675080 Free PMC article.
-
Psychiatric and Nonpsychiatric Comorbidities Among Children With ADHD: An Exploratory Analysis of Nationwide Claims Data in Germany.J Atten Disord. 2021 Apr;25(6):874-884. doi: 10.1177/1087054719865779. Epub 2019 Jul 31. J Atten Disord. 2021. PMID: 31364481
-
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.Cochrane Database Syst Rev. 2018 Aug 9;8(8):CD007813. doi: 10.1002/14651858.CD007813.pub3. Cochrane Database Syst Rev. 2018. PMID: 30091808 Free PMC article.
-
Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis.JAMA Netw Open. 2022 Nov 1;5(11):e2243597. doi: 10.1001/jamanetworkopen.2022.43597. JAMA Netw Open. 2022. PMID: 36416824 Free PMC article.
Cited by
-
Bidirectional association between atopic dermatitis and attention deficit hyperactivity disorder: a systematic review and meta-analysis.Ann Med. 2025 Dec;57(1):2483370. doi: 10.1080/07853890.2025.2483370. Epub 2025 Mar 30. Ann Med. 2025. PMID: 40159827 Free PMC article.
References
-
- Narishige R. Hyperactivity disorder (attention deficit/hyperactivity disorder ADHD). Jpn J Psychiatr Treat (2015) 44:567–72.
LinkOut - more resources
Full Text Sources